Oxford Gene Technology (OGT), has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.

Date 11 Dec 2019

Oxford Gene Technology (OGT), has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.

The new CytoSure™ NGS panel—launching early in 2020—will combine the strengths of microarrays and NGS to deliver a comprehensive all-in-one assay.

The new panel, in conjunction with OGT’s popular Interpret analysis software facilitates the accurate and confident detection of loss of heterozygosity (LOH), mosaicism and copy number variants (CNVs), in addition to those more traditionally assayed by NGS, single nucleotide variants (SNVs) and insertions/deletions (indels).

Oxford Gene Technology (OGT), has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.

Oxford Gene Technology (OGT), has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.

Answer the call for speakers & start-ups for CW's International Conference

Celebrating the Cambridge Tech Week Innovation Alley Award Winners

Optalysys wins the Business Weekly and Cambridge Tech Week Scale-Up Business Plan Competition

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

Oxford Gene Technology (OGT), has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.

You might also be interested in these articles

Answer the call for speakers & start-ups for CW's International Conference

Celebrating the Cambridge Tech Week Innovation Alley Award Winners

Optalysys wins the Business Weekly and Cambridge Tech Week Scale-Up Business Plan Competition

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs